Articles
Volume 5 Supplement 1
24th Congress of the International Association for Breast Cancer Research. Advances in human breast cancer research: preclinical models
- Meeting abstracts
- from 24th Congress of the International Association for Breast Cancer Research. Advances in human breast cancer research: preclinical models
- Sacramento, USA
- 1-5 November 2003
|
Oral presentation
Mouse models of human breast cancer: evolution or convolution? JE Green Breast Cancer Res 2003, 5(Suppl 1):1 (31 October 2003) |
|
Oral presentation
S-CJ Lin, K-F Lee, AY Nikitin, KM Bushnell, SG Hilsenbeck, RD Cardiff, A Li, K-W Kang, SA Frank, W-H Lee, EY-HP Lee Breast Cancer Res 2003, 5(Suppl 1):2 (31 October 2003) |
|
Oral presentation
Mouse models for BRCA1-associated breast cancer R-H Wang, W Li, X Xu, C Deng Breast Cancer Res 2003, 5(Suppl 1):3 (31 October 2003) |
|
Oral presentation
Integrin-mediated signal transduction in transgenic mouse models of human breast cancer DE White, S Blaess, U Mueller, S Dedhar, RD Cardiff, R St Arnaud, WJ Muller Breast Cancer Res 2003, 5(Suppl 1):4 (31 October 2003) |
|
Oral presentation
Reversibility and progression in conditional transgenic mouse models of breast cancer LA Chodosh, RB Boxer, SE Moody, BA Keister, CJ Sarkisian, JW Jang, GK Belka, CM Blakely, CP Portocarero, CJ Sterner, KL Notarfrancesco, EA Kauh Breast Cancer Res 2003, 5(Suppl 1):5 (31 October 2003) |
|
Oral presentation
Genetic manipulation of the mammary gland by transplantation P Edwards Breast Cancer Res 2003, 5(Suppl 1):6 (31 October 2003) |
|
Oral presentation
The Mutant Mouse Regional Resource Center Program KCK Lloyd Breast Cancer Res 2003, 5(Suppl 1):7 (31 October 2003) |
|
Oral presentation
SW Barthold Breast Cancer Res 2003, 5(Suppl 1):8 (31 October 2003) |
|
Oral presentation
Advanced immunophenotyping: more is better! N Baumgarth Breast Cancer Res 2003, 5(Suppl 1):9 (31 October 2003) |
|
Oral presentation
Whole Slide Imaging and telepathology J Galvez Breast Cancer Res 2003, 5(Suppl 1):10 (31 October 2003) |
|
Oral presentation
Mammary pathology of the genetically engineered mouse AD Borowsky Breast Cancer Res 2003, 5(Suppl 1):11 (31 October 2003) |
|
Oral presentation
Positron emission tomography and X-ray computed tomography: tools for mouse phenotyping? SR Cherry Breast Cancer Res 2003, 5(Suppl 1):12 (31 October 2003) |
|
Oral presentation
W Yang, C Kowal, E Sorensen, P Lassota Breast Cancer Res 2003, 5(Suppl 1):13 (31 October 2003) |
|
Oral presentation
Herceptin-sensitivity of HER2-transgenic mouse mammary tumors RH Schwall, P Hollingshead, S Erickson, J Winer, M Williams, D Dugger Breast Cancer Res 2003, 5(Suppl 1):14 (31 October 2003) |
|
Oral presentation
Role of animal models in oncology drug discovery R Kumar Breast Cancer Res 2003, 5(Suppl 1):15 (31 October 2003) |
|
Oral presentation
LM Wakefield, Y Yang, O Dukhanina, B Tang, M Mamura, JL Letterio, J Green, GT Merlino, MR Anver Breast Cancer Res 2003, 5(Suppl 1):16 (31 October 2003) |
|
Oral presentation
Development of a transgenic mouse line for the evaluation of the androgen receptor activity R Attar, C Cullinan, C-P Ho, M Swerdel, J Dell, RB Rowley, DJ Bol, J Ostrowski, K Mookhtiar, M Gottardis, R Weinmann Breast Cancer Res 2003, 5(Suppl 1):17 (31 October 2003) |
|
Oral presentation
Clinical breast cancer and estrogen HK Chew Breast Cancer Res 2003, 5(Suppl 1):18 (31 October 2003) |
|
Oral presentation
Pregnancy levels of estrogen prevents breast cancer S Nandi, RC Guzman, G Thordarson, L Rajkumar Breast Cancer Res 2003, 5(Suppl 1):19 (31 October 2003) |
|
Oral presentation
Steroid regulation of breast cancer cell proliferation RL Sutherland Breast Cancer Res 2003, 5(Suppl 1):20 (31 October 2003) |
|
Oral presentation
The ErbB receptor tyrosine kinases and their roles in cancer NE Hynes Breast Cancer Res 2003, 5(Suppl 1):21 (31 October 2003) |
|
Oral presentation
Predicting breast cancer behavior by microarray analysis M van de Vijver Breast Cancer Res 2003, 5(Suppl 1):22 (31 October 2003) |
|
Oral presentation
The molecular biology of mammary intraepithelial neoplasia outgrowths L Namba, SY Liu, ET McGoldrick, LJT Young, AD Borowsky, RD Cardiff, JP Gregg Breast Cancer Res 2003, 5(Suppl 1):23 (31 October 2003) |
|
Oral presentation
The comparative genetics and genomics of cancer: of mice and men G Hodgson, J Hager, K Chin, CA Lapuk, S Volik, C Collins, A Balmain, F Waldman, D Hanahan, J Gray Breast Cancer Res 2003, 5(Suppl 1):24 (31 October 2003) |
|
Oral presentation
Proof-of-concept CC Benz, P50-CA58207 Coinvestigators Breast Cancer Res 2003, 5(Suppl 1):25 (31 October 2003) |
|
Oral presentation
CL Arteaga Breast Cancer Res 2003, 5(Suppl 1):26 (31 October 2003) |
|
Oral presentation
The mouse in preclinical trials: transgenic, carcinogen-induced, or xenograph models – which to use? P Brown Breast Cancer Res 2003, 5(Suppl 1):27 (31 October 2003) |
|
Oral presentation
Transgenic models are predictive: the herceptin and flavopiridol experience E Schmidt Breast Cancer Res 2003, 5(Suppl 1):28 (31 October 2003) |
|
Oral presentation
Modeling breast cancer in the rat: a method to produce knockout rats MN Gould Breast Cancer Res 2003, 5(Suppl 1):29 (31 October 2003) |
|
Oral presentation
Genetically engineered mouse models of human breast cancer RA Jensen Breast Cancer Res 2003, 5(Suppl 1):30 (31 October 2003) |
|
Oral presentation
Role of differentiation in carcinogenesis and cancer prevention J Russo, IH Russo Breast Cancer Res 2003, 5(Suppl 1):31 (31 October 2003) |
|
Oral presentation
Genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat JD Shull, BS Schaffer, LM Bartsch, LK Buckles, KA Gould, M Tochacek, B Xie, CM Lachel, KL Pennington, TE Strecker, KK Hansen Breast Cancer Res 2003, 5(Suppl 1):32 (31 October 2003) |
|
Oral presentation
Transforming growth factor β's role in mammary gland development and carcinogenesis MH Barcellos-Hoff Breast Cancer Res 2003, 5(Suppl 1):33 (31 October 2003) |
|
Oral presentation
Hormonal interactions during mammary gland development BK Vonderhaar Breast Cancer Res 2003, 5(Suppl 1):34 (31 October 2003) |
|
Oral presentation
Function of LEF1 in early mammary development K Kratochwil, S Tontsch, R Grosschedl Breast Cancer Res 2003, 5(Suppl 1):35 (31 October 2003) |
|
Oral presentation
Expression profiling of breast cancer, influence of tumor genotype and patient genotype A-L Borresen-Dale Breast Cancer Res 2003, 5(Suppl 1):36 (31 October 2003) |
|
Oral presentation
S Ingvarsson Breast Cancer Res 2003, 5(Suppl 1):37 (31 October 2003) |
|
Oral presentation
Using genomic similarities and differences to interpret mouse models of human development and cancer L Stubbs, C Elso, G Loots, A Hamilton, I Ovcharenko Breast Cancer Res 2003, 5(Suppl 1):38 (31 October 2003) |
|
Oral presentation
A hybrid functional/anatomical imaging system for high-throughput planar projection mouse imaging JM Boone, K Yang Breast Cancer Res 2003, 5(Suppl 1):39 (31 October 2003) |
|
Oral presentation
Imaging mouse models of breast cancer with positron emission tomography S Cherry, C Abbey, S Borowsky, J Gregg, R Cardiff Breast Cancer Res 2003, 5(Suppl 1):40 (31 October 2003) |
|
Oral presentation
S Mandl, FG Blankenberg, Y-A Cao, C O'Connell-Rodwell, C Mari, TI Gaynutdinov, J-L Vanderheyden, MV Backer, JM Backer, C Contag Breast Cancer Res 2003, 5(Suppl 1):41 (31 October 2003) |
|
Oral presentation
Ultrasound imaging of tumor perfusion K Ferrara, P Dayton, R Pollard, A Broumas, E Wisner Breast Cancer Res 2003, 5(Suppl 1):42 (31 October 2003) |
|
Oral presentation
Advanced imaging and detection R&D in the Center for Biophotonics DL Matthews Breast Cancer Res 2003, 5(Suppl 1):43 (31 October 2003) |
|
Oral presentation
D Medina Breast Cancer Res 2003, 5(Suppl 1):44 (31 October 2003) |
|
Oral presentation
Mammary intraepithelial neoplasia outgrowths (MINO): MINO and human ductal carcinoma AD Borowsky Breast Cancer Res 2003, 5(Suppl 1):45 (31 October 2003) |
|
Oral presentation
Premalignancy in the human breast: how is it defined, is morphology good enough? BA Gusterson Breast Cancer Res 2003, 5(Suppl 1):46 (31 October 2003) |
|
Oral presentation
K Polyak Breast Cancer Res 2003, 5(Suppl 1):47 (31 October 2003) |
|
Oral presentation
Regulation of human mammary stem cells RB Clarke, E Anderson, A Howell, H Okano, CS Potten Breast Cancer Res 2003, 5(Suppl 1):48 (31 October 2003) |
|
Oral presentation
Characterization, isolation and cultivation of distinctive human breast cell populations R Villadsen, T Gudjonsson, A Fridriksdottir, M Wissing, L Rønnov-Jessen, MJ Bissell, OW Petersen Breast Cancer Res 2003, 5(Suppl 1):49 (31 October 2003) |
|
Oral presentation
Stem cells in normal breast development and breast cancer MS Wicha, G Dontu, M Al-Hajj, MF Clarke Breast Cancer Res 2003, 5(Suppl 1):50 (31 October 2003) |
|
Oral presentation
Functional characterization of mammary stem cells in development and breast cancer JM Rosen, BE Welm, SB Tepera, F Behbod, SL Grimm, T Venezia, MA Goodell, TA Graubert, Z Werb, Y Li, HE Varmus Breast Cancer Res 2003, 5(Suppl 1):51 (31 October 2003) |
|
Oral presentation
M Crépin, M DiBenedetto, R Bagheri-Yarmand, A Starzec, R Vassy, G Perret Breast Cancer Res 2003, 5(Suppl 1):52 (31 October 2003) |
|
Oral presentation
I McKenzie Breast Cancer Res 2003, 5(Suppl 1):53 (31 October 2003) |
|
Oral presentation
Mouse models for pretesting of immunotherapeutic strategies for cancer patients JM Burchell, DW Miles, A Mungul, T Plunkett, R Sewell, G Picco, I Correa, J Taylor-Papadimitriou Breast Cancer Res 2003, 5(Suppl 1):54 (31 October 2003) |
|
Oral presentation
ET Liu Breast Cancer Res 2003, 5(Suppl 1):55 (31 October 2003) |
|
Oral presentation
GD Yancopoulos Breast Cancer Res 2003, 5(Suppl 1):56 (31 October 2003) |
|
Oral presentation
Genomic approaches to drug target discovery using mouse models DW Morris Breast Cancer Res 2003, 5(Suppl 1):57 (31 October 2003) |
|
Oral presentation
Target discovery in the postgenomic era L Friedman, L Johnson, H Francis-Lang, M Costa, D Baly, G Duyk, G Plowman Breast Cancer Res 2003, 5(Suppl 1):58 (31 October 2003) |
|
Oral presentation
Rational engineering of Fc/Fc receptor interactions to improve antibody potency S Doberstein, G Lazar, R Hayes Breast Cancer Res 2003, 5(Suppl 1):59 (31 October 2003) |
|
Oral presentation
From gene expression patterns to antibody diagnostics DT Ross, BZ Ring, S Chang, Y Wang, C McDaniel, S Defoe, R Beck, R Seitz Breast Cancer Res 2003, 5(Suppl 1):60 (31 October 2003) |
|
Oral presentation
Clinical applications of Affymetrix Genechip arrays for RNA and DNA analysis I Russell Breast Cancer Res 2003, 5(Suppl 1):61 (31 October 2003) |
|
Oral presentation
Combined hormonal therapy for advanced breast cancer in postmenopausal patients P Langecker, W Lang, D Blanchett, P Bailey, C Scribner, P Goss Breast Cancer Res 2003, 5(Suppl 1):62 (31 October 2003) |
|
Oral presentation
CTLA-4 based therapy (MDX-010) A Korman Breast Cancer Res 2003, 5(Suppl 1):63 (31 October 2003) |
